NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden.
Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system.
Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.
Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system.
Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.
Employees: 11-50
Total raised: $7.63M
Founded date: 2016
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.11.2023 | - | $7.63M | - |
Mentions in press and media 22
| Date | Title | Description |
| 04.11.2024 | Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy | Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy Mon, Nov 04, 2024 06:30 CET Report this content Neogap Therapeutics, a Swedish clinical-stage biotechnology company, has ... |
| 25.06.2024 | Neogap granted Chinese patent for innovative method of MS treatment and diagnosis | Neogap granted Chinese patent for innovative method of MS treatment and diagnosis Tue, Jun 25, 2024 07:30 CET Report this content Neogap Therapeutics, a Swedish biotechnology company specialising in the development of personalised immunothe... |
| 26.03.2024 | Neogap secures Eurostars funding to develop T-cell activity analysis | Neogap secures Eurostars funding to develop T-cell activity analysis Tue, Mar 26, 2024 07:30 CET Report this content The Swedish biotech company Neogap Therapeutics has received SEK 5 million from Eurostars in a collaboration project with t... |
| 20.02.2024 | Neogap is granted Australian patent for innovative method of MS treatment and diagnosis | Neogap is granted Australian patent for innovative method of MS treatment and diagnosis Tue, Feb 20, 2024 07:30 CET Report this content The Swedish biotechnology company Neogap Therapeutics, which develops personalised immunotherapy, has be... |
| 09.11.2023 | Neogap raises SEK 83 million for a clinical phase I/II cancer study | Neogap raises SEK 83 million for a clinical phase I/II cancer study Thu, Nov 09, 2023 07:45 CET Report this content The Swedish biotechnology company Neogap Therapeutics announces that the company has raised SEK 54 million in a new share is... |
| 09.11.2023 | Sciety’s portfolio company Neogap raises SEK 83 million | Sciety’s portfolio company Neogap raises SEK 83 million Thu, Nov 09, 2023 09:00 CET Report this content Sciety och Sciety Venture Partners have invested SEK 54 million in Neogap Therapeutics (Neogap), a Swedish clinical-stage biotech compan... |
| 09.11.2023 | Sciety’s portfolio company Neogap raises SEK 83 million | PRESS RELEASE. Sciety och Sciety Venture Partners have invested SEK 54 million in Neogap Therapeutics (Neogap), a Swedish clinical-stage biotech company that develops personalised immunotherapy for cancer treatment with the help of two emer... |
| 17.08.2023 | Neogap winner of Business Sweden’s Catalyst Program | Neogap winner of Business Sweden’s Catalyst Program Thu, Aug 17, 2023 07:30 CET Report this content Swedish biotechnology company Neogap Therapeutics has been selected winner of Business Sweden’s Catalyst Program 2023. Neogap will gain a po... |
| 21.06.2023 | Neogap acquires TCER Oncology AB, strengthening its position in personalised immunotherapy | Neogap acquires TCER Oncology AB, strengthening its position in personalised immunotherapy Wed, Jun 21, 2023 07:00 CET Report this content Swedish biotechnology company Neogap Therapeutics, which is developing personalised immunotherapy, an... |
| 01.06.2023 | Neogap secures EU patent for innovative personalised immunotherapy technology | Neogap secures EU patent for innovative personalised immunotherapy technology Thu, Jun 01, 2023 07:30 CET Report this content The Swedish biotechnology company Neogap Therapeutics has secured a patent in the EU for their distinctive technol... |
Show more